Abstract:1459 Introduction: Actinium-225 (t1/2=10.0 d, 100% α) is considered as the next generation nuclide for Targeted radionuclide therapy (TRT). Ac-225 emits 4 α-particles and 2 β-particles in a row, which is considered as one of the most potent radionuclides against cancer. In general, ED50 of Ac-225 is 3-order lower than that of Lu-177. However, the limited supply of Ac-225 has hampered its research and further clinical application. In general, Actinium-225 is generated from Uranium-233 decay and the production of Ac-225 is <2 Ci per year. The other possible strategy to produce Ac-225 is from accelerator through 232Th(p, x)225Ac reaction on high-energy accelerator. In this study, we used 100 MeV protons to irradiate natural ThO2 target with CYCIAE-100 (100 MeV H-, 500 μA) and produced Ac-225. To isolate Ac-225 from other side products, we optimized the purification process, which consists of cation-exchange and solid-phase extraction with AG50W-X8 resin, DGA resin, and TRU resin to avoid liquid-liquid extraction. At last, high radiochemical purity Ac-225 product was obtained with ideal recovery rate. Methods: ThO2 powder was prepared as the target materials from analytically pure Th(NO3)4. The ThO2 powder was put into a niobium-made powder target and irradiated with about 2 μA 100 MeV proton (CYCIAE-100) and cooled with rapid airflow. 10 days cooling after end of beam (EOB), the irradiated ThO2 powder was dissolved in hot HNO3- HF and reconstituted in citric acid. AG50W-X8 cation exchanger resin, DGA resin and TRU resin were applied to the isolation process with solid-phase extraction. The qualitative and quantitative analysis of nuclear was done with HPGe Gamma-ray spectroscopy detector. Results: 619 µCi (EOB) of Ac-225 were produced with 7.18±1.08 mb experiment cross-sections. The abundance of Ac-225 of the irradiated ThO2 powder is still less than 3%, leading to the challenge for Ac-225 isolation. The optimized the purification process, which consists of cation-exchange and solid-phase extraction with AG50W-X8 resin, DGA resin, and TRU resin without liquid-liquid extraction, made the successful isolation for over 200 µCi of Ac-225 with radiochemical purity > 99.5%, recovery rate ~95% and < 4 hours time-cost. Conclusions: By using a 100 MeV cyclotron, we have successfully performed a pilot study of production and isolation of Ac-225, demonstrating the possibility of producing Ac-225 with the cyclotron in China.

225Ac production via 226Ra (μ−, n ν) 225Fr reaction with 226Ra target

Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n,x) Reaction in Pressurized Water Reactor

Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target

Actinium-225 Production with an Electron Accelerator

Effect of 226Ra purity as a target for 225Ac production using a fast reactor

Feasibility of Producing 225Ac via Thermal Neutron Irradiation of 226Ra: A Systematic Theoretical Study

Study on Production Method of the {sup 178m2}hf Isomer for Induced Gamma Emission

Research and Development for Cyclotron Production of 225Ac from 226Ra—The Challenges in a Country Lacking Natural Resources for Medical Applications

Potential production of Ac-225 at Egyptian second research reactor (ETRR-2) through neutron induced transmutation of Ra-226

Feasible Strategy for Large-Scale Production of 224ra As a Promising -Emitting Therapy Radionuclide

Production of 225 Ac for medical application from 232 Th-metallic targets in Nb-shells irradiated with middle-energy protons

Production and purification of molecular 225Ac at CERN-ISOLDE

Status of the 226Ra nuclear data library and its impact on the production amount of 225Ac via the 226Ra (n,2n) reaction

226Ra irradiation to produce 225Ac and 213Bi in an accelerator-driven system reactor

A Composite Target of a Radium Salt and a Soft Metal Matrix for Production of Ac-225 with a Proton or Electron Accelerator

A new method in the production of Ac-227, Ra-228, Th-228 and U-232 on Thorium target from different perspective for use in Radioisotope Power Systems and Nuclear Batteries

Production of No-Carrier-added 186re Via Deuteron Induced Reactions on Isotopically Enriched 186W

Production and Isolation of Actinium-225 for Targeted Radiotherapy with a 100 MeV Proton Cyclotron and Solid-Phase Extraction

The Cyclotron Production of Actinium-225 in CYCIAE-100

Actinium-225 Targeted Agents: Where Are We Now?

Automated Preparation of Actinium-225 with Accelerator-Based Production from Irradiated Natural Thorium Targets